Drugs / Allogenic Mesenchymal Stem Cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01956903 | Jan 2010 → Sep 2013 | chronic graft versus host disease | Grupo Espanol de trasplantes hematopoyeticos y terapia celular | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogenic Mesenchymal Stem Cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01956903 ↗ |
| Modality | Cell therapy | “Expanded in-Vitro Allogenic Mesenchymal Stem Cell” NCT01956903 ↗ |